Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

In this interview, Dr. John Bishop discusses the scientific and regulatory challenges of NAM adoption, where companies should ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, enabling timely medical guidance and informed decision-making.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries that use these ...

Background Chromosome 19 is the most gene-dense chromosome in the human genome, with a high frequency of segmental ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers. The life sciences tools and services ...

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive ...

A large meta-analysis of over 20,000 people found that modern genetic testing can identify a clinically meaningful cause of schizoprenia in about 1 in 16 patients (6%), especially in early-onset ...